• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/54

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

54 Cards in this Set

  • Front
  • Back
Ligand
Any molecule bound to a protein
Substrate
Specific ligand(s) bound to an enzyme that the enzyme is supposed to catalytically convert to a product.
Carriers
Hemoglobin (O2), transferrin (Fe++), albumin (fatty acids)
Receptors
Membrane bound (for hormones and other signals), immunoglobulins (for antigens), enzyme regulatory subunits (for regulatory metabolites)
Enzymes
Resemble receptors and carriers but chemically modify ligand (catalysis). Most common type of protein (70% of known proteins)
Units of dissociation constants
always in molalrity (micromolar or minimolar)
Kd
Dissociation constant. The affinity an enzyme has for the ligand.
Kd = [L][E]/[LE]
Ks
Affinity for the substrate. A dissociation constant.
Ks = [S][E]/[ES]
Ki
Affinity for an inhibitor. A dissociation constant.
Ki = [i][E]/[iE]
Km
A semi-dissociation constant. Affinity for the substrate. Defines the substrate concentration for 50% binding of the substrate or 50% action of the enzyme. Defined by the M-M equation.
Km = [S]({Kcat[E]/Kobs}-1)
Km = [S]({Vmax/v}-1)
Why these affinity constants are important
For a drug to be effective, it must compete with the regular substrate. Therefore its affinity constant (Ki) must complete with the enzyme's affinity for the regular substrate (Km).
Dissociation constants and the 2-log rule
Km and Ki signify the mid-point of the binding curve. The 2-log rule applies in this case as the affinities for substrate of enzymes are rarely variable. At a one log (or ten-fold) increase in concentration of the substrate, almost all of the enzyme will be loaded and active. At a ten-fold (or one log) decrease in the concentration of substrate, most enzymes will be empty. This is a hundred-fold total difference.
Enzymes' affinity for their substrate
The current "normal" concentrations of metabolites is controlled to be appropriate for the enzymes that use them. Also the enzymes have evolved to bind substrates that work well for their function and for the available concentration of the substrate.
Proper dosage of protein drugs
Drugs must be within the correct range to appropriately bind whatever enzyme is the target (Ki). Too low a concentration will ineffectively compete with the substrate (Ks). Too high a concentration (>10xKi), however, will saturate the system and cause inhibition or other effect on other enzymes or receptors. This is called a "side effect". Most harmful consequences of clinical drugs are caused by these unintended side effects.
Metabolism
Overall set of chemical reactions within a cell or organism.
Allosteric
"Other form". Means an enzyme that is regulated by conformational change between active and inactive forms.
Zygomen
Precursor form of an enzyme that is only activated by proteolysis.
Enzyme binding and naming
Most enzymes bind two substrates. A donor substrate is often a general molecule that is widely used in biosynthesis. The specific acceptor substrate is the molecule to which the enzyme will add moiety. Enzymes are often named for this acceptor substrate and the type of transfer.
Enzyme naming
Enzymes named for:
1. substrate + catalytic action + ase
ex. gluco + kin + ase
ribonucleotide reduct ase
2. Genes
ex. src, onc, ras
3. Size of protien
ex. p53, gp42, pp60
p = protein
gp = glycoprotein
pp = phosphoprotein

There are a few exception: pepsin, pepain, trypsin
named before creation of common naming trends.
Metal cofactors
More than 50% of enzymes use metal (ions) cofactors. Zn++, Fe++, Fe+++, Mg++, Cu++, K+, Mn++
Coenzyme
Complex organic cofactor
Enzyme Control
1. Enzymes react with only very specific substrates to create specific products.
2. Enzymes do not change the Keq for a reaction.
3. Enzymes increase the rate of the reaction by up to 10^17 (usually 10^5-10^9).
Ubiquity of enzyme activity
Every chemical reaction in the human body uses at least one enzyme.
Active site/catalytic site
Site on enzyme where substrate binds.
Enzyme action
Usually use induced fit to physically put substrate into position for faster rxn.
Enzymes and free energy of activation
Enzymes lower the free energy of reaction activation. This is the key to enhancing catalytic rates.
Enzymes and pH
Most humanenzymes function best at around 7 (pH of cells). Some have specific pHs though at which their activity is optimal. Usually has to do with environment. For example, pepsin in the stomach works best in an acidic environment. A dramatic change away from the optimal pH of an enzyme can reduce activity or render enzyme inactive.
Enzymes and temperature
Enzymes are effected by temp, but only at lower temps than body temp (37C). Higher temps increase non-catylized rxns, but at high temps, enzymes can be denatured. The lowest temp that works for enzymes in the body is the lowest temps the body can tolerate.
Evaluation of Enzyme activity
We are interested in the affinity of enzyme to their substrate and the velocity of action (v). The affinity is quantified by Km, the Michaelis-Menten constant.
Ki
If Ki for some inhibitor is low it has high affinity, if Ki is high, low affinity.
Amount of product formed depends on...
1. Time. More time = more product as long as enzyme and substrate concentrations are available.
2. Enzyme conc. More enzyme = more product.
3. Substrate conc. If substrate conc is high, will cause product until amount of product is sufficient and rxn stops.
Binding constants
Association constant: Ka, Dissociation constant: Kd
Substrate: Ks
Inhibitor: Ki
Unspecified ligand: KL

Always have units in molarity (micro or minimolar)
Kd
Affinity for any ligand.
Kd = [L][E]/[LE]
Ks
Affinity for any substrate.
Ks = [S][E]/[SE]
Ki
Affinity for any inhibitor.
Ki = [i][E]/[ES]
Km
Affinity for the substrate. Concentration of substrate when enzyme activity and/or binding is 50%.
Km = [S]({Kcat[E]/Kobs}-1)
Km = [S]({Vmax/v}-1)
Drug affinity for enzyme
In order for a drug (Ki) to be effective, must compete with substrate (Km) for binding with the target enzyme.
Affinity constants and the 2-log rule
Km and Ki represent the midpoint of a binding curve. In general, when the affinity is constant (as it is for most human enzymes), the range of enzyme activity ranges of 2-logs or 100-fold. From the mid-point, the addition of one log or 10 fold concentration of the substrate would cause almost all enzyme to be full and active. The ten fold or one log decrease in substrate concentration would cause most enzyme to be empty and inactive.
Substrate and Enzyme Concentrations
Most current metabolites are normally found in levels appropriate to the enzyme that processes them. Enzymes have evolved to interact with substrates that best fit their function and have adjusted to be at the correct concentrations for this substrate.
Side Effects and Drug concentrations
Drugs must be dosed specifically to target the enzyme they wish to inhibit. Too little will be insufficient to compete with substrate. Too much will cause likelihood of effecting/inhibiting other enzymes. This can cause "side effects". Most harmful consequences of clinical drugs are caused by these unintentional effects.
Velocity
v. The velocity or rate of a reaction. Units are usually nmol/min.

Vo =initial velocity
k and kx
rate of a single step in an overall reaction. Normal units are s^-1 (reciprocal seconds).

kx is the rate of a single step in a reaction sequence. Ex. k1, k2.
kcat
"Turnover number". Kcat = Vmax. Rate at which catalytic step of reaction takes place. Where actual chemistry occurs. Usually the slowest and therefore the absolute rate determining step.
Lineweaver-Burk Plots
Mathematical conversion of M-M plot (hyperbolic) gives a linear plot. Intercept on the y-axis to determine Vmax and intercept on x-axis to determine Km
Efficiency
Kcat/Km. Substrate has to find balance between fast and specific. If too specific (Km is low), the affinity for substrate is high and therefore the affinity for product is high and release is slower. If speed is too high (low Kcat), specificity is low.
Normal Values for Kcat/Km
Kcat is usually 10-10^3sec-1. If reaction must be very exact, Kcat will be slower. Values of 5x10^8-9M-1s-1 is near the upper limit of efficiency. For most enzymes, efficiency is around 10^-5 to 10^-7M-1s-1.
Normal cellular concentrations of enzymes and metabolites
Km is normally > or equal to [S]. Normal important substrates have conc. of 0.1-5mM (aa, carbs, nucleotides). Others are less abundant. Average conc. of all protein is ~1micromolar. [E] varies greatly, but in general:
low flux step: [E] = ~10-100nM
high flux step: [E] = 1-10micromolar
Enzyme inhibition
Inhibitors are usually analogs to the substrate and bind in the same place. Can be competitive or non-competitive (uncompetitive also exists). Ki only refers to reversible rxns. Covalent inhibition is irreversible.
Competitive inhibitors
Bind to same place as substrate and stop regular rxn from occurring. They can also add to another binding site, conformationally changing and de-activating enzyme. Competitive inhibitors do not actually change the affinity of enzyme for substrate, but do make Km ([S] for 50% bound) higher.
Non-competitive inhibitors
Inhibitor binds to enzyme so that substrate can still bind, but not well or enzyme is not as functional.
Ki and competition
Competition depends on affinities and concentrations of I and S. If Ki is less than Km, significant competition will occur. If [I] is close to Ki, significant inhibition will occur. Conc. of I must be half of conc. of E in order for Ki to occur.
Tight-binding inhibitors
If inhibitor is analog enough to substrate to stabilize the transition state of the enzyme, release will be slow and inhibition will be good.
Non-competitive inhibitors are better
In competitive inhibitors, substrate will build up due to non-processing, and will then out-compete inhibitor. Non-competitive is better.
Suicide Inhibitors
Covalently bond to enzyme making it inactive and unusable forever. This is good for drugs because by reducing the number of usable enzymes, drug dose can be reduced.